| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-783-60 | 62135-783 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET | ORAL | 20231016 | N/A | ANDA | ANDA211724 | Chartwell RX, LLC | CAPECITABINE | 150 mg/1 | 60 TABLET in 1 BOTTLE (62135-783-60) |
| 62135-784-12 | 62135-784 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET | ORAL | 20231016 | N/A | ANDA | ANDA211724 | Chartwell RX, LLC | CAPECITABINE | 500 mg/1 | 120 TABLET in 1 BOTTLE (62135-784-12) |
| 70756-816-22 | 70756-816 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET, FILM COATED | ORAL | 20200901 | N/A | ANDA | ANDA211724 | Lifestar Pharma LLC | CAPECITABINE | 500 mg/1 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70756-816-22) |
| 70756-815-60 | 70756-815 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET, FILM COATED | ORAL | 20200901 | N/A | ANDA | ANDA211724 | Lifestar Pharma LLC | CAPECITABINE | 150 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70756-815-60) |